| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Acumen Pharmaceuticals Inc. Common Stock (NASDAQ: ABOS)
ABOS Technical Analysis
3
| As on 6th Jan 2026 ABOS SHARE Price closed @ 1.96 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.45 & Buy for SHORT-TERM with Stoploss of 1.75 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ABOSSHARE Price
| Open | 1.98 | Change | Price | % |
| High | 2.05 | 1 Day | -0.02 | -1.01 |
| Low | 1.94 | 1 Week | -0.20 | -9.26 |
| Close | 1.96 | 1 Month | 0.40 | 25.64 |
| Volume | 165930 | 1 Year | -0.31 | -13.66 |
| 52 Week High 2.35 | 52 Week Low 0.90 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| OCG | 0.02 | -50.00% |
| WBA | 11.98 | 0.50% |
| NVDA | 187.24 | -0.47% |
| LMDX | 0.02 | 0.00% |
| SOFI | 26.98 | -7.86% |
| YGMZ | 0.02 | -66.67% |
| PLUG | 2.39 | 0.84% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ABOS Daily Charts |
ABOS Intraday Charts |
Whats New @ Bazaartrend |
ABOS Free Analysis |
|
|
ABOS Important Levels Intraday
| RESISTANCE | 2.17 |
| RESISTANCE | 2.10 |
| RESISTANCE | 2.06 |
| RESISTANCE | 2.02 |
| SUPPORT | 1.90 |
| SUPPORT | 1.86 |
| SUPPORT | 1.82 |
| SUPPORT | 1.75 |
ABOS Forecast January 2026
| 4th UP Forecast | 3.42 |
| 3rd UP Forecast | 2.95 |
| 2nd UP Forecast | 2.66 |
| 1st UP Forecast | 2.37 |
| 1st DOWN Forecast | 1.55 |
| 2nd DOWN Forecast | 1.26 |
| 3rd DOWN Forecast | 0.97 |
| 4th DOWN Forecast | 0.5 |
ABOS Weekly Forecast
| 4th UP Forecast | 2.54 |
| 3rd UP Forecast | 2.35 |
| 2nd UP Forecast | 2.24 |
| 1st UP Forecast | 2.12 |
| 1st DOWN Forecast | 1.80 |
| 2nd DOWN Forecast | 1.68 |
| 3rd DOWN Forecast | 1.57 |
| 4th DOWN Forecast | 1.38 |
ABOS Forecast2026
| 4th UP Forecast | 5.04 |
| 3rd UP Forecast | 4.05 |
| 2nd UP Forecast | 3.44 |
| 1st UP Forecast | 2.83 |
| 1st DOWN Forecast | 1.09 |
| 2nd DOWN Forecast | 0.48 |
| 3rd DOWN Forecast | -0.13 |
| 4th DOWN Forecast | -1.12 |
Acumen Pharmaceuticals Inc. Common Stock ( NASDAQ USA Symbol : ABOS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ABOS Business Profile
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia. Address: 427 Park St., Charlottesville, VA, United States, 22902
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service